Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma-Pooled analysis of two randomized trials-MedSci.cn

Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma-Pooled analysis of two randomized trials

Liu, X; Li, WF; Ding, C; Chen, L; Sun, Y; Li, JH; Ma, J; Zhang, Y

Ma, J; Zhang, Y (通讯作者)，Sun Yat sen Univ, Canc Ctr, State Key Lab Oncol South China, Dept Radiat Oncol,Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd East, Guangzhou 510060, Peoples R China.

ORAL ONCOLOGY, 2022; 125 ():

Abstract

Objective: Induction chemotherapy followed by concurrent chemoradiotherapy is the standard of care for patients with locoregionally advanced nasophary......

Full Text Link